Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial comparing allogeneic mesenchymal stem cell infusion to placebo in adults with major depressive disorder and alcohol use dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic human mesenchymal stem cell infusion (mesenchymal stem cells (allogeneic))

Snippet

Sponsor: Ihsan M Salloum, MD, MPH | Conditions: Major Depressive Disorder, Alcohol Use Disorder | Phase 1, Phase 2 | Status: COMPLETED